- Home
- NPKI vs ARCT Comparison
NPKI vs ARCT Comparison
Compare NPKI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- ARCT
- Stock Information
- Founded
- NPKI 1932
- ARCT 2013
- Country
- NPKI United States
- ARCT United States
- Employees
- NPKI N/A
- ARCT N/A
- Industry
- NPKI Metal Fabrications
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- ARCT Health Care
- Exchange
- NPKI Nasdaq
- ARCT Nasdaq
- Market Cap
- NPKI 665.2M
- ARCT 487.0M
- IPO Year
- NPKI N/A
- ARCT N/A
- Fundamental
- Price
- NPKI $7.67
- ARCT $17.12
- Analyst Decision
- NPKI
- ARCT Strong Buy
- Analyst Count
- NPKI 0
- ARCT 7
- Target Price
- NPKI N/A
- ARCT $65.00
- AVG Volume (30 Days)
- NPKI 376.9K
- ARCT 356.8K
- Earning Date
- NPKI 02-19-2025
- ARCT 03-06-2025
- Dividend Yield
- NPKI N/A
- ARCT N/A
- EPS Growth
- NPKI N/A
- ARCT N/A
- EPS
- NPKI N/A
- ARCT N/A
- Revenue
- NPKI $748,372,000.00
- ARCT $160,399,000.00
- Revenue This Year
- NPKI N/A
- ARCT $7.33
- Revenue Next Year
- NPKI N/A
- ARCT $4.71
- P/E Ratio
- NPKI N/A
- ARCT N/A
- Revenue Growth
- NPKI 93.70
- ARCT N/A
- 52 Week Low
- NPKI $5.61
- ARCT $14.30
- 52 Week High
- NPKI $8.65
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- ARCT 48.75
- Support Level
- NPKI N/A
- ARCT $15.82
- Resistance Level
- NPKI N/A
- ARCT $17.93
- Average True Range (ATR)
- NPKI 0.00
- ARCT 1.51
- MACD
- NPKI 0.00
- ARCT -0.04
- Stochastic Oscillator
- NPKI 0.00
- ARCT 23.90
About NPKI NPK International Inc. Common Stock
NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.